Pages that link to "Q36589870"
Jump to navigation
Jump to search
The following pages link to Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) immunotherapy for the treatment of prostate cancer (Q36589870):
Displaying 18 items.
- Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function (Q28246944) (← links)
- Inhibitors of B7-CD28 costimulation in urologic malignancies (Q33827752) (← links)
- B7-h3 and its role in antitumor immunity (Q34356712) (← links)
- Induction of the CTLA-4 gene in human lymphocytes is dependent on NFAT binding the proximal promoter (Q34907715) (← links)
- Innovative Therapies against Human Glioblastoma Multiforme (Q35374492) (← links)
- Phase I trial of tremelimumab in combination with short-term androgen deprivation in patients with PSA-recurrent prostate cancer (Q35951653) (← links)
- Cancer vaccines: moving beyond current paradigms (Q36868126) (← links)
- Human monoclonal antibodies from transgenic mice (Q37028982) (← links)
- Paradigm shifts in cancer vaccine therapy. (Q37122893) (← links)
- Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines (Q37181792) (← links)
- Anti-CTLA-4 antibody therapy associated autoimmune hypophysitis: serious immune related adverse events across a spectrum of cancer subtypes (Q37565259) (← links)
- Cryoimmunotherapy in urologic oncology (Q37598432) (← links)
- Update in systemic therapy of urologic malignancies. (Q38176143) (← links)
- Antibody therapeutics for treating prostate cancer: where are we now and what comes next? (Q39000185) (← links)
- Construction of CTLA-4-Ig Fusion Gene in pBudCE4.1 Expression Vector (Q41835568) (← links)
- Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy. (Q52661722) (← links)
- The functional cytotoxic T lymphocyte-associated Protein 4 49G-to-A genetic variant and risk of pancreatic cancer (Q56897841) (← links)
- Prognostic Value of Combined Analysis of CTLA-4 and PLR in Esophageal Squamous Cell Carcinoma (ESCC) Patients (Q93108682) (← links)